Connect Sign In
3001161
FLT3 ITD and TKD Mutation Detection
FLT3-PCR
Ordering Recommendation
Aids in the diagnosis and management of acute myeloid leukemia. Not intended for minimal residual disease monitoring.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Whole blood or bone marrow in lavender (EDTA).
Also acceptable: Whole blood in green (sodium heparin).
Specimen Preparation
Whole Blood: Do not freeze. Transport 5 mL whole blood. (Min: 1 mL)
Bone Marrow: Do not freeze. Transport 3 mL bone marrow. (Min: 1 mL)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Plasma, serum, FFPE tissue blocks/slides, or frozen tissue. Specimens collected in anticoagulants other than EDTA. Clotted or grossly hemolyzed specimens.
Remarks
Stability
Refrigerated: 7 days; Frozen: Unacceptable
Methodology
Capillary Electrophoresis
Performed
Varies
Reported
2-7 days
Reference Interval
Interpretive Data
Refer to report.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
81245; 81246
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3001162 | FLT3 Source | 31208-2 |
| 3001163 | ITD Result | 79210-1 |
| 3001164 | ITD Ratio | 92844-0 |
| 3001165 | TKD Result | 69548-6 |
| 3001166 | FLT3 ITD and TKD Mutation Detection | 50398-7 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- FLT3 CDX
- FLT3 D835
- FLT3 ITD
- FLT3 Mutant
- FLT3 Ratio
- FLT3 TKD
- FLT3 Signal Ratio
FLT3 ITD and TKD Mutation Detection
